D K Ornstein

Prostate-specific antigen as a screening test for prostate cancer. The United States experience.

D. Ornstein, G. Andriole, G L Andriole, 1997, The Urologic clinics of North America.

Molecular profiling of clinical tissue specimens: feasibility and applications.

G D Schuler, K H Buetow, P J Munson, 2000, The American journal of pathology.

Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines

E. Petricoin, D. Bostwick, C. Paweletz, 2000, Electrophoresis.

Molecular profiling of clinical tissues specimens: feasibility and applications.

G D Schuler, K H Buetow, P J Munson, 2000, The Journal of molecular diagnostics : JMD.

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.

D. Ornstein, W. Catalona, Deborah S. Smith, 1997, JAMA.

Prostate cancer: what is the future role for imaging?

C P Langlotz, J R Thornbury, P L Choyke, 2001, AJR. American journal of roentgenology.

Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.

P R Taylor, S M Hewitt, E. Petricoin, 2000, Cancer research.